EHNA

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
EHNA
EHNA.svg
Identifiers
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
Formula C14H24N5O
Molar mass 278.373 g/mol
3D model (JSmol)
  (verify)

EHNA (erythro-9-(2-hydroxy-3-nonyl)adenine) is a potent adenosine deaminase inhibitor,[1] which also acts as a phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type 2 (PDE2).[2][3]

References[edit]

  1. ^ "Sigma Aldrich". Retrieved 16 January 2013. 
  2. ^ Podzuweit, T; Nennstiel, P; Muller, A (1995). "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". Cell Signal. 7 (7): 733–8. doi:10.1016/0898-6568(95)00042-N. PMID 8519602. 
  3. ^ Méry, PF; Pavoine, C; Pecker, F; Fischmeister, R (1995). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes". Mol Pharmacol. 48 (1): 121–130. PMID 7623766.